ATE247664T1 - Peptide und diese enthaltende heilmittel für autoimmunkrankheiten - Google Patents

Peptide und diese enthaltende heilmittel für autoimmunkrankheiten

Info

Publication number
ATE247664T1
ATE247664T1 AT96908337T AT96908337T ATE247664T1 AT E247664 T1 ATE247664 T1 AT E247664T1 AT 96908337 T AT96908337 T AT 96908337T AT 96908337 T AT96908337 T AT 96908337T AT E247664 T1 ATE247664 T1 AT E247664T1
Authority
AT
Austria
Prior art keywords
amino acid
side chain
independently represents
acid residue
autoimmune diseases
Prior art date
Application number
AT96908337T
Other languages
English (en)
Inventor
Nobuyuki Yamagata
Kenji Ogata
Masako Wagatsuma
Hitoshi Takanashi
Original Assignee
Aventis Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Ltd filed Critical Aventis Pharma Ltd
Application granted granted Critical
Publication of ATE247664T1 publication Critical patent/ATE247664T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT96908337T 1995-04-07 1996-04-03 Peptide und diese enthaltende heilmittel für autoimmunkrankheiten ATE247664T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11759295 1995-04-07
JP7344649A JPH08333390A (ja) 1995-04-07 1995-11-24 ペプチド及びそれからなる自己免疫疾患治療剤
PCT/JP1996/000917 WO1996031529A1 (fr) 1995-04-07 1996-04-03 Peptides et medicaments contre les maladies auto-immunes contenant ces peptides

Publications (1)

Publication Number Publication Date
ATE247664T1 true ATE247664T1 (de) 2003-09-15

Family

ID=26455689

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96908337T ATE247664T1 (de) 1995-04-07 1996-04-03 Peptide und diese enthaltende heilmittel für autoimmunkrankheiten

Country Status (13)

Country Link
EP (1) EP0821003B1 (de)
JP (1) JPH08333390A (de)
KR (1) KR19980703610A (de)
CN (1) CN1183784A (de)
AT (1) ATE247664T1 (de)
AU (1) AU704656B2 (de)
CA (1) CA2217679C (de)
DE (1) DE69629559T2 (de)
ES (1) ES2203685T3 (de)
HU (1) HUP9801680A3 (de)
NO (1) NO974566L (de)
NZ (1) NZ304437A (de)
WO (1) WO1996031529A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858210B1 (en) 1998-06-09 2005-02-22 La Jolla Pharmaceutical Co. Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same
IL125262A0 (en) 1998-07-07 1999-03-12 Yeda Res & Dev Synthetic peptides and pharmaceutical compositions comprising them
US6913749B2 (en) 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
US6935730B2 (en) 2000-04-03 2005-08-30 Unicorn Image Products Co. Ltd. Of Zhuhai One-way valve, valve unit assembly, and ink cartridge using the same
US7232898B2 (en) 2002-05-21 2007-06-19 Resistentia Pharmaceuticals Ab Chimeric IgE polypeptides and host cells
CN1169829C (zh) * 2002-06-27 2004-10-06 北京大学人民医院 非t细胞结合肽及其用途
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
EP3305802B1 (de) 2015-05-26 2021-05-12 Gemvax & Kael Co., Ltd. Anti-inflammatorische, anti-fibrotische und wundheilende octapeptide und deren zusammensetzungen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2072356A1 (en) * 1989-12-29 1991-06-30 James L. Urban Diagnosis and treatment of diseases
RO117329B1 (ro) * 1991-06-24 2002-01-30 Chiron Corp Emeryville Polipeptide care contin o secventa a virusului hepatitei c
JPH06511241A (ja) * 1991-09-23 1994-12-15 ジェネンテク,インコーポレイテッド 自己免疫疾患の診断および治療
JPH08501554A (ja) * 1992-09-14 1996-02-20 ブリガム・アンド・ウイメンズ・ホスピタル 慢性関節リウマチの治療剤および治療方法

Also Published As

Publication number Publication date
AU5162296A (en) 1996-10-23
EP0821003A4 (de) 2000-05-24
NZ304437A (en) 1999-01-28
DE69629559D1 (de) 2003-09-25
NO974566D0 (no) 1997-10-02
HUP9801680A2 (hu) 1998-11-30
AU704656B2 (en) 1999-04-29
WO1996031529A1 (fr) 1996-10-10
MX9707662A (es) 1997-11-29
DE69629559T2 (de) 2004-06-17
KR19980703610A (ko) 1998-12-05
JPH08333390A (ja) 1996-12-17
CA2217679A1 (en) 1996-10-10
NO974566L (no) 1997-11-26
EP0821003B1 (de) 2003-08-20
CA2217679C (en) 2008-03-25
CN1183784A (zh) 1998-06-03
ES2203685T3 (es) 2004-04-16
EP0821003A1 (de) 1998-01-28
HUP9801680A3 (en) 1999-06-28

Similar Documents

Publication Publication Date Title
US8524861B2 (en) Treatment of bacterial infections
AU4837300A (en) Antimicrobial theta defensins and methods of using same
IL112641A (en) Broad spectrum antimicrobial compounds and pharmaceutical compositions containing them
CA2399187C (en) Kahalalide compounds
DE68916932T2 (de) Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus.
JPH11505721A (ja) プロテグリン
ATE247664T1 (de) Peptide und diese enthaltende heilmittel für autoimmunkrankheiten
Gross α, β-Unsaturated and related amino acids in peptides and proteins
Karlsson Chemistry of some potent animal toxins
CA2453112A1 (en) New cationic peptides of the dermaseptin family isolated from the skin secretion of phyllomedusa hypochondrialls
JP4293889B2 (ja) 塩基性抗菌性ペプチドを有効成分とする細胞増殖剤
MY147920A (en) Antibacterial and antiviral peptides from actinomadura namibiensis
WO1997002287A1 (en) Parevins and tachytegrins
US6307016B1 (en) Parevins and tachytegrins
US20180072775A1 (en) Beta-Hairpin Peptidomimetics
US6982246B1 (en) Cytomodulating peptide for inhibiting lymphocyte activity
US20230295234A1 (en) Antimicrobial peptidomimetics
EP3173421A1 (de) Als antibakterielle wirkstoffe nützliche, peptidische verbindungen
US6790829B1 (en) Cyclic decapeptide antibiotics
RU94004998A (ru) Хризоспермины, способ их получения, лекарственное средство на их основе и штамм apiocrea chrysosperma
AU714294C (en) Parevins and tachytegrins
CA2963224A1 (en) Beta-hairpin peptidomimetics
USRE38828E1 (en) Parevins and tachytegrins
Defferrari Synthesis of an α-AApeptide derived from an antibiofilm RNase peptid
EP4214220A1 (de) Antimikrobielle peptidomimetika

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0821003

Country of ref document: EP

REN Ceased due to non-payment of the annual fee